Tocotrienols as an anti-osteoporotic agent: The progress so far

International Journal of Osteoporosis and Metabolic Disorders

Volumn 4, Issue 1, 2011, Pages 1-14

  Nazrun, A S ^a   Norazlina, M ^a   Norliza, M ^a   Ima Nirwana, S ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Anti oxidant; Calcium; Osteocalcin; R sorption; Vitamin E

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE BONE ISOENZYME; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; CALCIUM; CYCLOOXYGENASE 2; DEXAMETHASONE; ESTROGEN; FREE RADICAL; GAMMA TOCOTRIENOL; GLUCOCORTICOID; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; LIOTHYRONINE; MALONALDEHYDE; NICOTINE; SUPEROXIDE DISMUTASE; TESTOSTERONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THYROXINE;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANDROGEN DEFICIENCY; ANTIOXIDANT ACTIVITY; ARTICLE; BONE DENSITY; BONE MINERALIZATION; BONE REMODELING; BONE TURNOVER; CALCIUM BONE LEVEL; CANCELLOUS BONE; CORTICOSTEROID INDUCED OSTEOPOROSIS; DRUG MECHANISM; DRUG MEGADOSE; ESTROGEN DEFICIENCY; HUMAN; HYPERTHYROIDISM; LIPID PEROXIDATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; OXIDATIVE STRESS; POSTMENOPAUSE OSTEOPOROSIS; SMOKING; TRABECULAR BONE; VITAMIN SUPPLEMENTATION;

EID: 79956083406     PISSN: 19945442     EISSN: 20772157     Source Type: Journal    
DOI: 10.3923/ijom.2011.1.14     Document Type: Article

References (85)

1. Abe, T., J.W.M. Chow, J.M. Lean and T.J. Chambers, 1993. Estrogen does not restore bone lost after ovariectomy in the rat. J. Bone Mineral Res., 8: 831-838.
2. Ahmad, N.S., B.A.K. Khalid, D.A. Luke and S. Ima-Nirwana, 2005. Tocotrienol offers better protection than tocoherol from free radical-induced damage of rat bone. Clin. Exp. Pharm. Physiol, 32: 761-770.
3. Asayama, K., K. Dobashi, H. Hayashibe, Y. Megata and K. Kato, 1987. Lipid peroxidation and free radical scavengers in thyroid dysfunction in the rat: a possible mechanism of injury to heart and skeletal muscle in hyperthyroidism. Endocrinology, 121: 2112-2118.
4. Asmadi, A.Y., A. Adam, W.Z. Wan Ngah, M. Norazlina and Y. Kamisah et al., 2005. Tocotrienols and a-Tocopherol reduced acute and chronic lung lipid peroxidation induced by paraquat in rats. Pak. J. Nutr.,4:97-100.
5. Badeau, M., H. Adlercreutz, P. Kaihovaara and M.J. Tikkanen, 2005. Estrogen A-ring structure and antioxidative effect on lipoproteins. J. Steroid Biochem. Mol. Biol., 96: 271-278.
6. Baldwin, S., 2001. Control of oncogenesis and cancer therapy resistance by the transcription factor NFKB. J.Clm. Invest, 107: 241-246.
7. Balena, R, A. Markatos, M. Gentile, P. Masarachia and J.G. Seedor et al., 1993. The aminobisphosphanate alendronate inhibits bone loss induced by thyroid hormone in the rats. Comparison between effects on tibiae and vertebrae. Bone, 14: 499-504.
8. Basu, S, K. Michaelsson, H. Olofsson, S. Johansson and H. Melhus, 2001. Association between oxidative stress and bone mineral density. Biochem. Biophys. Res. Commun, 288: 275-279.
9. Beckman, B.S, A.K. Bahn and R.G. Allen, 1989. Superoxide dismutase induces differentiation of friend erythroleukemia cells. J. Cell Physiol, 139: 370-376.
10. Berger, CE.M, B.R. Horrocks and H.K. Datta, 1999. Direct non-genomic effect of steroid hormones on Superoxide anion generation in bone resorbing osteoclasts. Mol. Cell. Endocrinol, 149: 53-59.
11. Cappuccio, F.P, E. Meilahn, J. Zmuda, J. Cauley and A. Siani et al., 1999. High blood pressure and bone mineral loss in elderly white women: A prospective study. Study of osteoporotic fractures research group. A prospective study of hypertension and the incidence of kidney stones in men. Lancet, 354: 971-975.
12. Chavassieux, P, P. Pastoureau, M.C. Chapuy, P.D. Delmas and P.J. Meunier, 1993. Glucocorticoid-induced inhibition of osteoblastic bone formation in ewea: A biochemical and histomorphometric study. Osteoporosis Int., 3: 97-102.
13. Christensen, J.O. and O.L. Svendsen, 1999. Bone mineral in pre- and post menopausal women with insulin-dependent and non-insulin dependent diabetes mellitus. Osteoporos. Int., 10: 307-311.
14. Conte, C, A. Flondi, C. Aisa, M. Piroddi, A. Floridi and F. Galh, 2004. Gamma-tocotnenol metabolism and antiproliferative effect in prostate cancer cells. Ann. N. Y. Acad. Sei, 1031:391-394.
15. Daniell, H.W, 1976. Osteoporosis of slender smoker. Vertebral compression fractures and loss of metacarpal cortex in relation to postmenopausal cigarette smoking and lack of obesity. Arch. Internal Med, 136: 298-304.
16. De Vernejoul, M.C, A. Pomtillart, C. Golenzer, C. Morieux and C. Bielakoff et al, 1984. Effects of iron overload on bone remodeling in pigs. Am. Pathol, 116: 377-384.
17. Deyhim, F, E. Lopez, J. Gonzalez, M. Garcia and B.S. Patil, 2006. Citrus juice modulates antioxidant enzymes and lipid profiles in orchidectomized rats. J. Med. Food, 9: 422-426.
18. Deyhim, F., A. Villarreal, K. Garcia, R. Rios and C. Garcia et al., 2007. Orange pulp improves antioxidant status and suppresses lipid peroxidation in orchidectomized male rats. Nutrition, 23:617-621.
19. Ebina, Y., S. Okada, S. Hamazaki, Y. Toda and O. Midorikawa, 1991. Impairment of bone formation with aluminum and ferric nitrilotriacetate complexes. Calcified Tissue Int., 48: 28-36.
20. Fang, M.A., P.J. Frost, A. lika-Klein and T.J. Hahn, 1991. Effects of nicotine on cellular function m UMR 106-01 osteoblast-hke cells. Bone, 12: 283-286.
21. Garnero, P., V. Vassy, A. Bertholin, J.P. Riou and P.D. Delmas, 1994. Markers of bone turnover in hyperthyroidism and the effects of treatment. J. Clin. Endocrinol. Metab., 78: 955-959.
22. Garrett, I.R., B.F. Boyce, R.O. Oreffo, L. Bonewald, J. Poser and G.R. Mundy, 1990. Oxygen-derived free radicals stimulate osteoclastic bone résorption in rodent bone in vitro and in vivo. J. Clin. Invest, 85: 632-639.
23. Goldstein, M.F, J.J. Fallon and R. Harning, 1999. Chronic glucocorticoid therapy-induced steoporosis patients with obstructive lung disease. Chest, 116: 1733-1749.
24. Gunness, M. and E. Orwoll, 1996. Early induction of alteration in cancellous and cortical bone histology after orchidectomy in mature rats. J. Bone Mineral Res, 11: 1531-1538.
25. Gutteridge, J.M, DA. Rowley and B. Halliwell, 1982. Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Detection of catalytic iron and antioxidant activity in extracellular fluids. Biochem. J, 206: 605-609.
26. Hammer, C.T. and E.D. Wills, 1978. The role of lipid components of the diet in the regulation of the fatty acid composition of the rat liver endoplasmic reticulum and lipid peroxidation. Biochem. J, 174: 585-593.
27. Hasselwander, O, K. Kramer, P.P. Hoppe, U. Oberfrank and K. Baldenius et al., 2002. Effects of feeding various tocotrienol sources on plasma lipids and aortic atherosclerotic lesions in cholesterol-fed rabbits. Food Res. Int., 35: 245-251.
28. Hermizi, H, O. Faizah, S. Ima-Nirwana, S. Ahmad-Nazrun, D.A. Luke and M. Norazlina, 2007. Negative effects of nicotine on bone resorbing cytokines and bone histomorphometric parameters in male rats. J. Bone Min. Metab, 25: 93-98.
29. Hermizi, H, O. Faizah, S. Ima-Nirwana, A.S. Nazrun, D.A. Luke and M. Norazlina, 2009. Beneficial effects of tocotrienol on bone histomorphometric parameters in Sprague-Dawley male rats after nicotine cessation. Calcified Tissue Int., 84: 65-74.
30. Ima-Nirwana, S, M. Norazlina and B.A.K. Khalid, 1998. Pattern of bone mineral density in growing male and female rats after gonadectomy. J. Asean. Fed. Endoc. Soc, 16: 21-26.
31. Ima-Nirwana, S, A. Kiftiah, T. Sariza, M.T. Gapor and B.A.K. Khalid, 1999. Palm vitamin E improves bone metabolism and survival rate in thyrotoxic rats. Gen. Pharm, 32: 621-626.
32. Ima-Nirwana, S, A. Kiftiah, A.G. Zamal, M.A. Norazlina, M.T. Gapor and B.A.K. Khalid, 2000. Palm vitamin E prevents osteoporosis in orchidectomised growing male rats. Nat. Prod. Sei, 6: 155-160.
33. Ima-Nirwana, S. and H. Fakhrurazi, 2002. Palm vitamin E protects bone against examethasone-induced osteoporosis in male rats. Med. J. Malaysia, 57: 133-141.
34. Ima-Nirwana, S. and S. Suhaniza, 2004. Effects of tocopherols and tocotrienols on body composition and bone calcium content in adrenalectomised rats replaced with Dexamethasone. J. Med. Food, 7:45-51.
35. Ima-Nirwana, S, C.T. Cheng and M. Norazlina, 2005. Effects of nicotine on bone mineral density and calcium homeostasis in male Sprague-Dawley rats. Curr. Topics Pharm, 9: 125-129.
36. Jaya, D.S., J. Agustine and V.P. Menon, 1995. Protective effect of testosterone against alcohol and paracetamol induced hepatotoxicity in rats. Indian J. Exp. Biol., 33: 194-200.
37. Jee, W.S.S., 1995. Animal models in the prevention and treatment of osteopenia: Forward. Bone, 17: 113S-114S.
38. Jenkinson, T. and A.K. Balla, 1993. A reappraisal of steroid induced osteoporosis. Br. J. Hospital Med, 50: 472-476.
39. Kalpana, C. and V.P. Menon, 2004. Protective effect of circumin on circulatory lipid peroxidation and antioxidant status during nicotine-induced toxicity. Toxicol. Mech. Methods, 14: 339-343.
40. Kalu, D.N., C.C. Liu, R.R. Hardin and B.W. Hollis, 1989. The aged rat model of ovarian hormone deficiency bone loss. Endocrinology, 124: 7-16.
41. Kalu, D.N., 1991. The ovariectomized rat model of postmenopausal bone loss. Bone Miner., 15: 175-191.
42. Kamer, A.R., N. El-Ghorab, N. Marzec, J.E. Margarone and R. Dziak, 2006. Nicotine induced proliferation and cytokine release in osteoblastic cells. Int. J. Mol. Med., 17: 121-127.
43. Khalkah-Ellis, Z, P. Collm-Osdoby, L. Li, M.L. M.L. Brandi and P. Osdoby, 1997. A human homolog of the 150 kD avian osteoclast membrane antigen related to Superoxide dismutase and essential for bone résorption is induced by developmental agents and opposed by estrogen in FLG29. Calcified Tissue Int., 60: 187-193.
44. Law, M.R. and A.K. Hackshaw, 1997. A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ., 315: 841-846.
45. Lean, J.M., C.J. Jagger, B. Kirstein, K. Fuller and T.J. Chambers, 2005. Hydrogen peroxide is essential for estrogen-deficiency bone loss and osteoclast formation. Endocrinol, 146: 728-735.
46. Leb, G., H. Warnkrob and B. Obermayer-Pietsch, 1994. Thyroid hormone excess and osteoporosis. Acta Med. Austnaca, 21: 65-67.
47. Looker, A.C., E.S. Orwoll, C.C. Johnston, R.L. Lindsay and H.W. Wahner et al., 1997. Prevalence of low femoral bone density in older U.S. adults from NHANES III. J. Bone Mineral Res., 12: 1761-1768.
48. Maggio, D., M. Barabani, M. Pierandrei, M.C. Polidori and M. Catani et al., 2003. Marked decrease in plasma antioxidants in aged osteoporotic women: Results of a cross-sectional study. J. Clin. Endo. Metab, 88: 1523-1527.
49. Malcolm, A.J., 2002. Metabolic bone disease. Curr. Diagnose Pathol., 8: 19-25.
50. Maniam, S., N. Mohamed, A.N. Shuid and I.N. Soelaiman, 2008. Palm tocotrienol exerted better antioxidant activities in bone than alpha-tocopherol. Basic Clin. Pharmacol. Toxicol., 103: 55-60.
51. Mosekilde, L. and L. Mosekilde, 1990. Sex-difference in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone, 11: 67-73.
52. Mosekilde, L., 1995. Assessing bone quality-animal models in preclinical osteoporosis research. Bone, 17: 343S-352S.
53. Nesaretnam, K, R. Ambra, K.R. Selvaduray, A. Radhakrishnan, R. Canali and F. Virgili, 2004. Tocotrienol-rich fraction from palm oil and gene expression in human breast cancer cells. Ann. N. Y. Acad. Sei., 1031: 143-157.
54. NOF, 2004. Disease Statistics. National Osteoporosis Foundation, Washington, D.C.
55. Norazlma, M., S. Ima-Nirwana, M.T. Gapor and B.A.K. Khahd, 2000. Palm vitamin E is comparable to alpha-tocopherol in maintaining bone mineral density in ovariectomised female rats. Exp. Clin. Endocrinol. Diab., 108: 305-310.
56. Norazlina, M., H.L.R. Ling and S. Ima-Nirwana, 2002a. The effects of vitamin E or calcium supplementation on bone mineral composition in vitamin E deficient rats. Malaysia J. Biochem. Biol, 7: 1-5.
57. Norazlina, M., S. Ima-Nirwana, M.T. Abd Gapor and B.A.K. Khalid, 2002b. Tocotrienols are needed for normal bone calcification in growing female rats. Asia Pacific J. Clin. Nutr., 11: 194-199.
58. Norazlina, M., Y.M.K. Nik-Fandeh, A. Arizi, A. Faisal and S. Ima-Nirwana, 2004. Effects of nicotine on bone resorbing cytokines in male rats. Int. Med. J., 3: 1-9.
59. Norazlina, M., H.I. Lukman, A.S. Nazrun and S. Ima-Nirwana, 2007. Effects of vitamin E supplementation on bone metabolism in nicotine-treated rats. Singapore Med. J., 48: 195-199.
60. Nur Azlina, M.F., M.I. Nafeeza and B.A.K. Khalid, 2005. Effect of tocotrienol on lipid peroxidation in experimental gastritis induced by restraint stress. Pak. J. Nutr., 4: 69-72.
61. Omi, N. and I. Ezawa, 1995. The effect of ovariectomy on bone metabolism in rats. Bone, 17: 163S-168S.
62. Ongphiphadhanakul, B., S. Alex, L.E. Braverman and D.T. Baran, 1992. Excessive L-thyroxine therapy decreases femoral bone mineral densities in the male rat: effect of hypogonadism and calcitonin. J. Bone Mineral Res., 7: 1227-1231.
63. Ortoft, G. and H. Oxlund, 1996. Qualitative alteration of cortical bone in female rats after long term administration of growth hormones and glucocorticoids. Bone, 18: 581-590.
64. Orzechowski, A., P. Ostaszewski, A. Brodnicka, J. Wilczak and M. Jank et al., 2000. Excess of glucocorticoid impairs whole-body antioxidant status in young rats, relation to the effect of dexamethasone in soleus muscle and spleen. Hormone Metab. Res., 32: 174-180.
65. Parhami, F., A.D. Marrow, J. Balucan, N. Leitinger and A.D. Watson et al., 1997. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation, a possible explanation for the paradox of arterial calcification in osteoporotic patients. Aterioscler. Thromb. Vase. Biol., 17: 680-687.
66. Parhami, F., A. Garfinkel and L.L. Demer, 2000. Role of lipids in osteoporosis. Aterioscler. Thromb. Vase. Biol, 20: 2346-2348.
67. Pearce, B.C., R.A. Parker, M.E. Deason, A.A. Qureshi and J.J.K Wright, 1992. Hypercholesterolaemic activity of synthetic and natural tocotrienols. J. Med. Chem, 35: 3595-3606.
68. Pereira, B, E.J. Bechara, J.R. Mendonca and R. Curi, 1999. Superoxide dismutase, catalse and glutathione peroxidase activities in the lymphoid organs and skeletal muscles of rats treated with dexamethasone. Cell Biochem. Function, 17: 15-19.
69. Porter, S.E. and E.N. Henley, 2001. The musculoskeletal effects of smoking. J. Am. Acad. Orthopaedic Surgeons, 9: 9-17.
70. Rosen, H.N, S. Tollin, R. Balena, V.L. Middlebrook and A.C. Moses et al., 1995. Bone density is normal in male rats treated with finasteride. Endocrinology, 136: 1391-1397.
71. Sack, M.N, D.J. Rader and R.O. Cannon, 1994. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet, 343: 269-270.
72. Scutt, A, P. Bertram and M. Brautigan, 1996. The role of glucocoticoids and prostaglansin E2 in the recruitment of bone marrow mesenchymal cells to the osteoblastic lineage: positive and negative effects. Calcified Tissue Int., 59: 154-162.
73. Serbinova, E, V. Kagan, D. Han and L. Packer, 1991. Free radical recycling and intramembrane mobility in the antioxidant properties of a tocopherol and a-tocotrienol. Free Radical Biol. Med, 10: 263-275.
74. Shoutens, A., M. Verhas, M.L. Hermite-Baleriaux, M. Lhermite and A. Verschaeren et al., 1984. Growth and bone haemodynamic responses to castration in male rats. Reversibilty by testosterone. Acta Endocrinol., 107: 428-432.
75. Sontakke, A.N. and R.S. Tare, 2002. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin. Chim. Acta, 318: 145-148.
76. Sreelatha, K.T., V.P. Menon and S. Leelamma, 1993. Testosterone and lipid peroxide etabolism in orchidectomised rats. Indian J. Exp. Biol., 31: 323-326.
77. Stepan, J.J., M. Lachman, J. Zverina, V. Pacovsky and D.J. Baylink, 1989. Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling. J. Clin. Endocrinol. Met ab., 69: 523-527.
78. Suarna, C, R.L. Hood, R. Dean and R. Stocker, 1993. Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system and in rat and human lipoproteins. Biochimica Biophysica Acta, 1166: 163-170.
79. Suleyman, H., K. Gumustekin, S. Taysi, S. Keles and N. Oztasan et al., 2002. Beneficial effects of Hippophae rhamnoides L. on nicotine induced oxidative stress in rat blood compared with vitamin E. Biol. Pharm. Bull, 25: 1133-1136.
80. Takeuchi, K, S. Okada, S. Yukihiro and H. Inoue, 1997. The inhibitory effects of aluminium and iron on bone formation, In vivo and In vitro study. Pathophysiology, 4: 97-104.
81. Wetscher, G.J, M. Bagchi, D. Bagchi, G. Perdikis and P.R. Hinder et al., 1995. Free radical production in nicotine treated pancreatic tissue. Free Radical Biol. Med, 18: 877-882.
82. Wu, S.J, P.L. Liu and L.T. Ng, 2008. Tocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells. Mol. Nutr. Food Res, 52: 921-929.
83. Yang, S, Y. Zhang, R.M. Rodrigmz, W.L.Ries and L.L. Key, 1996. Functions of the M-CSF receptors on osteoclasts. Bone, 18: 355-360.
84. Yee, J.K. and S. Ima-Nirwana, 1998. Palm vitamin E protects bone against ferricnitrilotriacetate- induced impairment of calcification. Asia Pacific J. Pharmacol, 13: 35-41.
85. Yeung, K.W, F. Griffith, E. Antonio, K.H. Lee, J. Woo and P.C. Leung, 2005. Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: A proton MR spectroscopy study. J. Magnetic Resonance Imaging, 22: 279-285.